About

Matthew Walsh has served as a Certara director since 2020 and chairs the Audit Committee. He has been Executive Vice President and CFO of Organon & Co. since June 2020, was CFO of Allergan plc from 2018 until its 2020 acquisition by AbbVie, and served as CFO of Catalent, Inc. from 2008 to 2018. He holds a B.S. in Chemical Engineering and an MBA, both from Cornell University.

Roles

Certara, Inc.
Director (Independent) · Current role
2020–present
Allergan plc
EVP & CFO (2018-2020)
—
Catalent, Inc.
CFO (2008-2018)
—
Escala Group, Inc.
President, CFO & Acting CEO (2006-2008)
—

External Roles

Organon & Co.
EVP & Chief Financial Officer
—

Also at Certara, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.